Clinics in Dermatology
Volume 28, Issue 5 , Pages 546-548 , September 2010

Treatment of genital warts: Facts and controversies

References 

  1. Skerlev M, Grce M, Sirotkoviae-Skerlev M, Husnjak K, Lpozencic J. Human papillomavirus male genital infections: clinical variations and the significance of DNA typing. Clin Dermatol. 2002;20:173–178
  2. Mlakar B. Anoscopy could be beneficial for women with external anogenital condyloma. Eur J Obstet Gynecol Reprod Biol. 2007;133:121–122
  3. Schoenfeld A, Ziv E, Levavi H, Samra Z, Oadia J. Laser versus loop electrosurgical excision in vulvar condyloma for eradication of subclinical reservoir demonstrated by assay for 2′5′ oligosynthetase human papillomavirus. Gynecol Obstet Invest. 1995;40:46–51
  4. Syed TA, Lndin S. Topical treatment of penile condylomata acuminata with podophyllotoxin 0.3% solution, 0.3% cream and 0.15% cream. A comparative open study. Dermatology. 1993;187:30–33
  5. Padilla-Ailhaud A. Carbon dioxide laser vaporization of condyloma acuminata. J Low Genit Tract Dis. 2006;10:238–241
  6. Mayeaux EJ, Harper MB, Barksdale W, Pope JB. Noncervical human papillomavirus genital infections. Am Fam Physician. 1995;52:1137–1150
  7. Savoca S, Nardo LG, Rosano TF, D'Agosta S, Nrdo F. CO(2) laser vaporization as primary therapy for human papillomavirus lesions. A prospective observational study. Acta Obstet Gynecol Scand. 2001;80:1121–1124
  8. Lacey CJ, Goodall RL, Tennvall GR, et al. Randomised controlled trial and economic evaluation of podophyllotoxin solution, podophyllotoxin cream, and podophyllin in the treatment of genital warts. Sex Transm Infect. 2003;79:270–275
  9. Ault KA. Epidemiology and natural history of human papillomavirus infections in the female genital tract. Infect Dis Obstet Gynecol. 2006;14:40470
  10. Lacey CJ. Therapy for genital human papillomavirus-related disease. J Clin Virol. 2005;32(Suppl 1):S82–S90
  11. Lacey CJ, Lowndes CM, Sah KV. Chapter 4: burden and management of non-cancerous HPV-related conditions: HPV-6/11 disease. Vaccine. 2006;24(Suppl 3):S35–S41
  12. Gross G, Ikenberg H, Gissmann L, Hgedorn M. Papillomavirus infection of the anogenital region: correlation between histology, clinical picture, and virus type. Proposal of a new nomenclature. J Invest Dermatol. 1985;85:147–152
  13. Vandepapeliere P, Barrasso R, Meijer CJ, et al. Randomized controlled trial of an adjuvanted human papillomavirus (HPV) type 6 L2E7 vaccine: infection of external anogenital warts with multiple HPV types and failure of therapeutic vaccination. J Infect Dis. 2005;192:2099–2107
  14. Brown DR, Schroeder JM, Bryan JT, Stoler MH, Ffe KH. Detection of multiple human papillomavirus types in condylomata acuminata lesions from otherwise healthy and immunosuppressed patients. J Clin Microbiol. 1999;37:3316–3322
  15. Sheary B, Dyan L. Cervical screening and human papillomavirus. Aust Fam Physician. 2005;34:578–580
  16. Mao C, Hughes JP, Kiviat N, et al. Clinical findings among young women with genital human papillomavirus infection. Am J Obstet Gynecol. 2003;188:677–684
  17. Koutsky L. Epidemiology of genital human papillomavirus infection. Am J Med. 1997;102:3–8
  18. Koutsky LA, Galloway DA, Hlmes KK. Epidemiology of genital human papillomavirus infection. Epidemiol Rev. 1988;10:122–163
  19. Herrero R, Castle PE, Schiffman M, et al. Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica. J Infect Dis. 2005;191:1796–1807
  20. Moscicki AB, Shiboski S, Broering J, et al. The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women. J Pediatr. 1998;132:277–284
  21. Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med. 1998;338:423–428
  22. Franco EL, Villa LL, Sobrinho JP, et al. Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer. J Infect Dis. 1999;180:1415–1423
  23. Evander M, Edlund K, Gustafsson A, et al. Human papillomavirus infection is transient in young women: a population-based cohort study. J Infect Dis. 1995;171:1026–1030
  24. Rosa MI, Fachel JM, Rosa DD, Medeiros LR, Igansi CN, Bozzetti MC. Persistence and clearance of human papillomavirus infection: a prospective cohort study. Am J Obstet Gynecol. 2008;199:617.e1–617.e7
  25. Sycuro LK, Xi LF, Hughes JP, et al. Persistence of genital human papillomavirus infection in a long-term follow-up study of female university students. J Infect Dis. 2008;198:971–978
  26. Macnab JC, Walkinshaw SA, Cordiner JW, Clements JB. Human papillomavirus in clinically and histologically normal tissue of patients with genital cancer. N Engl J Med. 1986;315:1052–1058
  27. Workowski KA, Berman SM. Sexually transmitted diseases treatment guidelines, 2006. MMWR Recomm Rep. 2006;55:1–94
  28. Centers for Disease Control and Prevention. Report to Congress: prevention of genital human papillomavirus infection (Jan 2004). Atlanta (Ga): CDC; 2004;

PII: S0738-081X(10)00037-4

doi: 10.1016/j.clindermatol.2010.03.013

Clinics in Dermatology
Volume 28, Issue 5 , Pages 546-548 , September 2010

Article Tools